23-25 JANUARY 2017 // MIAMI
E-newsletter sign up
Sample attendee list
Tweets by @Phacilitate
It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer.
Lance Leopold MD, Vice President, Head of Oncology Development, Incyte Corporation